Journal of Neural Transmission

Title Publication Date Language Citations
The significance of neuroinflammation in understanding Alzheimer’s disease2006/10/13English178
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease2002/03/01178
Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts1998/01/01177
Lewy body-related ?-synucleinopathy in the aged human brain2004/04/02English176
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain2000/03/15176
EEG coherence in Alzheimer?s dementia2003/09/01173
Cognitive dysfunction and dementia in Parkinson?s disease2004/06/30English173
The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy2006/02/09English169
Brain iron metabolism and its perturbation in neurological diseases2010/09/01English168
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies2017/12/08English165
Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study2012/11/02English164
Oxidative stress potentiates BACE1 gene expression and A? generation2004/12/22English163
Early cortical processing of natural and artificial emotional faces differs between lower and higher socially anxious persons2008/09/11English162
Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis1998/01/01159
Hippocampal neurons in schizophrenia2002/05/01159
Cognitive demands and cortical control of human balance-recovery reactions2007/06/08English156
CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging2000/05/03155
Recent advances in our understanding of neurodegeneration2009/06/05English155
Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm2005/06/15English154
Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA2008/02/12English150
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit2002/07/01149
Kynurenine metabolism in Alzheimer's disease1999/03/17149
An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease2000/02/09148
Magnetic resonance imaging for the diagnosis of Parkinson’s disease2017/04/04English148
Early stages (P100) of face perception in humans as measured with event-related potentials (ERPs)2004/12/07English147
Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders2004/07/01English143
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies2001/12/01143
Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study2012/10/18English143
Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study2011/01/19English142
Allelic variation in 5-HT 1A receptor expression is associated with anxiety- and depression-related personality traits2003/12/01141